Clinical parameters | OS | DFS | ||||
---|---|---|---|---|---|---|
No.a | HR (95% CI)b | p | No.a | HR (95% CI)b | p | |
Age |  |  | <  0.001 |  |  | 0.001 |
 ≤ 60 years | 67 | 1 |  | 67 | 1 |  |
 > 60 years | 58 | 2.96 (1.63–5.36) |  | 56 | 2.45 (1.42–4.23) |  |
Lymph node status | Â | Â | 0.055 | Â | Â | 0.118 |
 N0 | 70 | 1 |  | 69 | 1 |  |
 N1/N2/N3 | 55 | 1.74 (0.99–3.07) |  | 54 | 1.53 (0.90–2.59) |  |
Tumor size | Â | Â | 0.117 | Â | Â | 0.204 |
 ≤ 20 mm | 33 | 1 |  | 33 | 1 |  |
 > 20 mm | 91 | 1.83 (0.86–3.92) |  | 89 | 1.54 (0.79–2.98) |  |
Histological grade | Â | Â | 0.915 | Â | Â | 0.600 |
 II | 21 | 1 |  | 21 | 1 |  |
 III | 104 | 1.04 (0.49–2.23) |  | 102 | 1.22 (0.58–2.59) |  |
KLK12 mRNAc | Â | Â | 0.037 | Â | Â | 0.010 |
 Negative | 61 | 1 |  | 59 | 1 |  |
 Positive | 54 | 1.91 (1.04–3.50) |  | 54 | 2.12 (1.19–3.78) |  |
KLK12 mRNA posd | Â | Â | 0.047 | Â | Â | 0.051 |
 Low | 16 | 1 |  | 16 | 1 |  |
 High | 38 | 2.98 (1.02–8.74) |  | 38 | 2.64 (1.00–6.96) |  |